This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AI-powered tools have the ability to leverage machine learnings to identify patterns in the data, have predictive analytics to suggest trends, flag opportunities to drive cost, and more importantly, help reduce human errors to make informed decisions. And thank you to all of you for taking the time out of your day to read this article!
.–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. 7 Many groups, including marginalised racial and ethnic groups, women, and other populations are underrepresented in clinical trials.
Each week, well be providing a look back at the articles we posted and why theyre important to the healthcare IT community. RCM automation vendor Candid Health raised $52.5 Lindus Health raised $55 million in Series B funding ; the company executes clinical trials for lifescience organizations.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Article 
117 
Let's personalize your content